id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-0968-0007,FDA,FDA-2013-E-0968,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:27:19Z,,0,0,090000648243dfe2
FDA-2013-E-0968-0006,FDA,FDA-2013-E-0968,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-12-07T05:00:00Z,2015,12,2015-12-07T05:00:00Z,,2015-12-07T17:57:26Z,,0,0,0900006481d8a548
FDA-2013-E-0968-0005,FDA,FDA-2013-E-0968,"Determination of Regulatory Review Period for Purposes of Patent
Extension; OVUGEL",Notice,Determinations,2015-05-07T04:00:00Z,2015,5,2015-05-07T04:00:00Z,2015-11-04T04:59:59Z,2015-05-07T16:16:28Z,2015-11003,0,0,0900006481ad2894
FDA-2013-E-0968-0004,FDA,FDA-2013-E-0968,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-04-23T04:00:00Z,2015,4,2015-04-23T04:00:00Z,,2015-04-23T13:00:40Z,,0,0,0900006481ab5ed8
FDA-2013-E-0968-0003,FDA,FDA-2013-E-0968,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-03-26T04:00:00Z,2014,3,2014-03-26T04:00:00Z,,2014-03-26T12:35:00Z,,0,0,0900006481680815
FDA-2013-E-0968-0002,FDA,FDA-2013-E-0968,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-08-15T04:00:00Z,2013,8,2013-08-15T04:00:00Z,,2013-08-15T13:24:13Z,,0,0,09000064813b26d7
FDA-2013-E-0968-0001,FDA,FDA-2013-E-0968,The Penn State Research Foundation and Massettutes Institute of Technology - Patent Term Application,Other,Application,2013-08-15T04:00:00Z,2013,8,2013-08-15T04:00:00Z,,2013-08-15T13:24:13Z,,0,0,09000064813b26d5